<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="180638">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00743158</url>
  </required_header>
  <id_info>
    <org_study_id>X08-01-0060</org_study_id>
    <nct_id>NCT00743158</nct_id>
  </id_info>
  <brief_title>Transfer Impedance in Cystic Fibrosis</brief_title>
  <acronym>Ztr</acronym>
  <official_title>Transfer Impedance in Cystic Fibrosis (Ztr)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <brief_summary>
    <textblock>
      This study aims to determine whether respiratory system transfer impedance (Ztr) may fill an
      important clinical function by providing a reproducible, valid, and sensitive measure of
      airway obstruction in people with CF.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cystic Fibrosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Cystic Fibrosis Patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 2 to 25 Confirmed diagnosis of Cystic Fibrosis

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Childrens Hospital, Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lamia Momen, BA</last_name>
      <phone>617-355-6665</phone>
      <email>lamia.momen@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas R Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <lastchanged_date>August 19, 2009</lastchanged_date>
  <firstreceived_date>August 27, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Thomas Martin, MD</name_title>
    <organization>Childrens Hospital, Boston</organization>
  </responsible_party>
  <keyword>ztr</keyword>
  <keyword>transfer impedance</keyword>
  <keyword>cystic fibrosis</keyword>
  <keyword>pulmonary function test</keyword>
  <keyword>pft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
